Free Trial

CryoPort (CYRX) Competitors

CryoPort logo
$10.12 -0.59 (-5.51%)
Closing price 10/17/2025 04:00 PM Eastern
Extended Trading
$10.24 +0.12 (+1.23%)
As of 10/17/2025 07:38 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

CYRX vs. COGT, GPCR, BHVN, STOK, ABCL, IMCR, VCEL, JANX, EWTX, and RCUS

Should you be buying CryoPort stock or one of its competitors? The main competitors of CryoPort include Cogent Biosciences (COGT), Structure Therapeutics (GPCR), Biohaven (BHVN), Stoke Therapeutics (STOK), AbCellera Biologics (ABCL), Immunocore (IMCR), Vericel (VCEL), Janux Therapeutics (JANX), Edgewise Therapeutics (EWTX), and Arcus Biosciences (RCUS). These companies are all part of the "pharmaceutical products" industry.

CryoPort vs. Its Competitors

Cogent Biosciences (NASDAQ:COGT) and CryoPort (NASDAQ:CYRX) are both small-cap pharmaceutical products companies, but which is the better investment? We will compare the two companies based on the strength of their profitability, earnings, risk, analyst recommendations, institutional ownership, dividends, media sentiment and valuation.

CryoPort has a net margin of 37.21% compared to Cogent Biosciences' net margin of 0.00%. CryoPort's return on equity of -9.79% beat Cogent Biosciences' return on equity.

Company Net Margins Return on Equity Return on Assets
Cogent BiosciencesN/A -223.82% -89.44%
CryoPort 37.21%-9.79%-5.42%

Cogent Biosciences presently has a consensus target price of $19.67, indicating a potential upside of 19.99%. CryoPort has a consensus target price of $12.56, indicating a potential upside of 24.07%. Given CryoPort's stronger consensus rating and higher possible upside, analysts clearly believe CryoPort is more favorable than Cogent Biosciences.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Cogent Biosciences
1 Sell rating(s)
4 Hold rating(s)
7 Buy rating(s)
2 Strong Buy rating(s)
2.71
CryoPort
1 Sell rating(s)
1 Hold rating(s)
8 Buy rating(s)
1 Strong Buy rating(s)
2.82

Cogent Biosciences has a beta of 0.3, indicating that its stock price is 70% less volatile than the S&P 500. Comparatively, CryoPort has a beta of 1.61, indicating that its stock price is 61% more volatile than the S&P 500.

92.9% of CryoPort shares are held by institutional investors. 7.3% of Cogent Biosciences shares are held by insiders. Comparatively, 10.0% of CryoPort shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

In the previous week, Cogent Biosciences had 3 more articles in the media than CryoPort. MarketBeat recorded 5 mentions for Cogent Biosciences and 2 mentions for CryoPort. CryoPort's average media sentiment score of 0.49 beat Cogent Biosciences' score of 0.26 indicating that CryoPort is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Cogent Biosciences
1 Very Positive mention(s)
1 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
CryoPort
0 Very Positive mention(s)
2 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

CryoPort has higher revenue and earnings than Cogent Biosciences. Cogent Biosciences is trading at a lower price-to-earnings ratio than CryoPort, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cogent BiosciencesN/AN/A-$255.86M-$1.78-9.21
CryoPort$228.38M2.22-$114.76M$1.337.61

Summary

CryoPort beats Cogent Biosciences on 14 of the 16 factors compared between the two stocks.

Get CryoPort News Delivered to You Automatically

Sign up to receive the latest news and ratings for CYRX and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CYRX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CYRX vs. The Competition

MetricCryoPortTRANS IndustryTransportation SectorNASDAQ Exchange
Market Cap$536.22M$5.49B$7.21B$10.50B
Dividend YieldN/A2.57%471.65%4.81%
P/E Ratio7.6110.7315.1027.09
Price / Sales2.221.16522.87210.58
Price / CashN/A10.897.8661.22
Price / Book1.362.922.416.52
Net Income-$114.76M$183.91M$555.48M$276.75M
7 Day Performance8.82%93.85%20.18%2.00%
1 Month Performance0.70%-4.82%-2.03%2.26%
1 Year Performance34.04%-13.18%2.88%35.58%

CryoPort Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CYRX
CryoPort
3.1695 of 5 stars
$10.12
-5.5%
$12.56
+24.1%
+41.9%$536.22M$228.38M7.611,186News Coverage
High Trading Volume
COGT
Cogent Biosciences
1.8709 of 5 stars
$16.20
-0.4%
$20.00
+23.5%
+40.8%$1.85BN/A-9.1080News Coverage
Analyst Forecast
GPCR
Structure Therapeutics
3.3923 of 5 stars
$30.19
+0.4%
$68.67
+127.4%
-30.9%$1.73BN/A-28.75136News Coverage
BHVN
Biohaven
3.4378 of 5 stars
$15.29
-3.3%
$48.85
+219.6%
-69.0%$1.67BN/A-2.00239
STOK
Stoke Therapeutics
3.4055 of 5 stars
$30.34
+0.5%
$27.43
-9.6%
+152.7%$1.65B$36.56M35.69100
ABCL
AbCellera Biologics
2.3137 of 5 stars
$5.67
+2.5%
$8.00
+41.1%
+108.6%$1.65B$28.83M-10.31500Gap Up
IMCR
Immunocore
1.9367 of 5 stars
$32.35
-0.2%
$56.89
+75.9%
-0.6%$1.63B$310.20M-80.88320
VCEL
Vericel
3.3326 of 5 stars
$33.49
+5.1%
$60.40
+80.4%
-13.2%$1.61B$237.22M279.11300News Coverage
Analyst Upgrade
Analyst Revision
JANX
Janux Therapeutics
2.3427 of 5 stars
$26.29
-0.8%
$78.31
+197.9%
-46.3%$1.59B$10.59M-14.6130News Coverage
EWTX
Edgewise Therapeutics
3.1291 of 5 stars
$14.71
-2.6%
$38.83
+164.0%
-57.6%$1.59BN/A-9.4960
RCUS
Arcus Biosciences
2.3868 of 5 stars
$16.64
+14.0%
$26.78
+61.0%
-9.6%$1.55B$258M-5.25500Gap Up

Related Companies and Tools


This page (NASDAQ:CYRX) was last updated on 10/18/2025 by MarketBeat.com Staff
From Our Partners